Alzheimer's Society responds to the Autumn Budget announcement of £600 million in social care funding and what this might ...
The MHRA have approved donanemab for the treatment of Alzheimer’s disease. However, NICE does not recommend use on the NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback